At Abcalis® we understand your needs. Our recombinant antibody services provide highest quality, individual customization & adaptability:
Target antigen design, procurement and quality control
Design of panning strategies tailored to deliver antibodies with the desired properties. Selection of antibodies in several rounds of phage display panning
Screening ELISA in scFv format (other assays and formats on request)
Sequencing, annotation and in silico analysis to identify promising candidates
Cloning into full IgG format of your choice, choose your Fc species, many other formats available as well
Antibody production in HEK cell system, choose from various purification and characterisation options
Are you facing troubles in your assays related to reproducibility?
Do you need an antibody against a new target that simply does not yet exist?
Or do you want to replace your limited batch size animal-based antibody solution?
At Abcalis® we can generate antibodies tailored to your needs from our diverse antibody phage display libraries. We take care of all steps from selection to protein production and initial validation.
The best part about it: Your final product will be completely animal-free.
Do you want to convert your Hybridoma into a recombinant antibody to truly immortalize it?
Do you need one of your sequence defined antibodies with a different Fc part?
At Abcalis® we can bestow your antibody with any Fc part from any species. Additionally, we have created several special formats that may be of use to you:
Delivery of known sequence or sequencing of antibody gene
Design of DNA / gene delivery or gene synthesis
Primer design & PCR
Cloning into full IgG format of your choice
Antibody production in HEK cell system
Do you want to improve your competitive small molecule ELISA?
Abcalis provides an antibody discovery service that transforms competitive small molecule immunoassays into sandwich ELISA formats. Our approach enables the generation of highly specific antibodies that selectively recognize the target only when bound to its specific capture antibody. This innovation allows for enhanced signal amplification, leading to increased assay sensitivity and robustness.
By eliminating the constraints of competitive ELISA, our technology enables a more flexible detection method for small molecules in diagnostics and research applications.